Zolidyne

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Zolidyne
Generic name: PYRITHIONE ZINC
Manufacturer: Topiderm, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 6d5eaecc-a3a1-4739-ae5b-66df4a15cd21
SPL ID: 34c76824-3047-41a6-805a-a17e63e0c019
Version: 7
Effective date: 2019-11-20
Source export date: 2026-10-12
Source partition: 5
Source file: https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/13cbfcd236c665f0ee69e2d9141331148dcdff45d1679c92f029cfba27dd74a2/drug-label-0005-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:43:45

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M032	openfda.application_number
brand name		Zolidyne	openfda.brand_name
generic name		PYRITHIONE ZINC	openfda.generic_name
manufacturer name		Topiderm, Inc.	openfda.manufacturer_name
ndc	package	51326-203-67	openfda.package_ndc
ndc	product	51326-203	openfda.product_ndc
ndc11	package	51326020367	derived:openfda.package_ndc
rxcui		244458	openfda.rxcui
spl id		34c76824-3047-41a6-805a-a17e63e0c019	id
spl set id		6d5eaecc-a3a1-4739-ae5b-66df4a15cd21	set_id
unii		R953O2RHZ5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water If condition worsens or does not improve after regular use of this product as directed, consult a doctor If condition covers a large area of the body, consult your doctor before using this product Keep out of reach of children. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.